BABA
Alibaba Group Holding Limited
BABA has the edge over DKS overall, supported by stronger valuation.
DKS
DICK'S Sporting Goods, Inc.
DKS has lower modeled downside risk, despite its lower overall score.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
DKS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Under pressure | |
| Healthy |
DKS's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA has the edge over DKS in the historical PE scenario, which offers more potential upside but is not a forecast.
DKS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.3x | $84.34 | -42% |
| Forward | 12x | $146 | — |
| Fair | 14x | $124 | -15% |
| Current | 16x | $146 | — |
| Expensive | 18x | $162 | +11% |
Historical ranges are pointers, not guarantees.
DKS's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its fair range.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over DKS on the outlook, with more favorable revenue expectations.
DKS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect DKS's earnings to grow and its profitability to improve, with its revenue holding steady.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over DKS on earnings, with stronger typical year-over-year growth.
DKS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.44 | +37% |
| Q3 2026 | $9.06 | -37% |
| Q2 2026 | $10.27 | -27% |
| Q1 2026 | $9.97 | -29% |
| Q4 2025 | $12.44 | -11% |
| Q3 2025 | $14.33 | +5.1% |
| Q2 2025 | $13.99 | +16% |
| Q1 2025 | $14.05 | +15% |
| Q4 2024 | $13.99 | +25% |
DKS's earnings per share have fallen from their peak: $9.06 over the past year, against $14.33 in mid-2025.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
DKS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.6B | +53% |
| Q2 2026 | $5.2B | +63% |
| Q1 2026 | $6.2B | +60% |
| Q4 2025 | $4.2B | +36% |
| Q3 2025 | $3.6B | +5% |
| Q2 2025 | $3.2B | +5.2% |
| Q1 2025 | $3.9B | +0.5% |
| Q4 2024 | $3.1B | +0.5% |
DKS has the edge over BABA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.9% | -4.5 points |
| Q2 2026 | 8.7% | -2.8 points |
| Q1 2026 | 3% | -7 points |
| Q4 2025 | 2.2% | -7.1 points |
| Q3 2025 | 12% | -1.1 points |
| Q2 2025 | 12% | +0.6 points |
| Q1 2025 | 9.9% | +0.3 points |
| Q4 2024 | 9.4% | +0.4 points |
DKS has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
DKS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $133M | -55% |
| Q2 2026 | -$84.2M | +$2.5M |
| Q1 2026 | $706.2M | +79% |
| Q4 2025 | -$515.6M | -$376.3M |
| Q3 2025 | $296.2M | +65% |
| Q2 2025 | -$86.7M | -217% |
| Q1 2025 | $394.5M | -33% |
| Q4 2024 | -$139.3M | -$49.6M |
DKS has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has the edge over DKS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
DKS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -277K shares |
| 1 year | +11% | +9.1M shares |
| 3 years | +3.9% | +3.3M shares |
| 5 years | -18% | -19.1M shares |
| Available history | +4.1% | +3.5M shares |
DKS has 90M diluted shares, up 11% from a year ago, despite $185M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $141.2M |
| Q1 2026 | $43.5M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $303.7M |
| Q1 2025 | $92.8M |
| Q4 2024 | $6.7M |
DKS spent $185M buying back its own shares over the past year, down 54% from the year before.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
DKS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 0.0x | Very low |
DKS's net debt is less than a year of its operating earnings (EBITDA).
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
DKS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.2 | Neutral |
| Stochastic | 24.3 | Neutral |
DKS's weekly RSI is 38 (neutral) and its Stochastic is 24 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
DKS PE vs Consumer Cyclical Sector
| Metric | DKS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 11% below |
| PE % | 71 | 47 | 24 pts above |
DKS has the edge over BABA on valuation relative to its sector.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
DKS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $141.1 | 3.3% above |
| 20 week MA | $166.3 | 12% below |
| 50 week MA | $194.2 | 25% below |
| 100 week MA | $202.5 | 28% below |
| 200 week MA | $184.0 | 21% below |
DKS has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
DKS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.2 | $55.6 | +15% |
| 2021 | $55.6 | $103.9 | +87% |
| 2022 | $103.9 | $111.1 | +6.9% |
| 2023 | $111.1 | $147.0 | +32% |
| 2024 | $147.0 | $234.1 | +59% |
| 2025 | $234.1 | $210.3 | -10% |
| 2026 YTD | $210.3 | $145.7 | -31% |
DKS has the edge over BABA on returns for 2026, with the stronger performance.